August 10, 2021

In this MD Newsline exclusive interview with cancer researcher Dr. Hadiyah-Nicole Green, Ph.D., we discuss cancer survival and cancer mortality among Black Americans. MD Newsline: Why do Black Americans have the highest death rate and shortest survival of any racial/ethnic group in the United States for most cancers?  Dr. Hadiyah-Nicole Green, Ph.D.: “African Americans have...

In this MD Newsline exclusive interview with cancer researcher Dr. Hadiyah-Nicole Green, Ph.D., we discuss some of the challenges and disparities that cancer researchers have faced during the COVID-19 pandemic. MD Newsline: What are some of the challenges and disparities that cancer researchers have faced in the wake of COVID-19? Dr. Hadiyah-Nicole Green, Ph.D.: “During...

In this MD Newsline exclusive interview with cancer researcher Dr. Hadiyah-Nicole Green, Ph.D., we discuss how to improve messaging on prostate cancer screening, breast cancer screening, and cervical cancer screening for African Americans. MD Newsline: How might we improve messaging surrounding prostate cancer screening, breast cancer screening, and cervical cancer screening?  Dr. Hadiyah-Nicole Green, Ph.D.:...

Timeliness of treatment is an important metric for multiple myeloma treatment. This study, published in Anticancer Research, focuses on the impact of the Affordable Care Act (ACA) on initial treatment delay for patients with multiple myeloma.  The researchers relied on data from the National Cancer Database and included patients diagnosed with multiple myeloma between 2004 and 2016....

Multiple myeloma primarily affects older adults. Yet, this population is less likely to participate in clinical trials and is thus less likely to benefit from treatment advances. This study, published in the Journal of Geriatric Oncology, focuses on the treatment and outcome differences experienced by younger adults and older adults with multiple myeloma.   The study included...